Marlborough's Verax Biomedical has renewed its commercialization agreement with Fresenius Kabi USA, allowing for the marketing and distribution of a Verax in-vitro diagnostic test that detects bacterial contaminants in donated platelets.
Boston Scientific, the Marlborough medical device manufacturer and developer, announced a voluntary worldwide recall of a device used to remove small blood clots from coronary arteries during thrombectomy procedures.
CeQur has broken ground on an expansion of its Marlborough facility that will double its size and allow it to increase the workforce by 100 over the next two years.
Marlborough medical device firm ReWalk Robotics on Tuesday named industry veteran Peter L. Wehrly to permanently take over the position on its nine-member board of directors held on an interim basis by an Israeli venture capitalist.
The Quest Diagnostics clinical laboratory in Marlborough has received a Leadership in Energy and Environmental Design (LEED) certification from the U.S. Green Building Council.